Scientific and ethical consequences of disease prediction.
D000328:Adult; D017668:Age of Onset; D000755:Anemia, Sickle Cell / Q000175:diagnosis / Q000517:prevention & control; D001675:Bioethics; D002648:Child; D002908:Chronic Disease; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000517:prevention & control; D003661:Decision Support Techniques; D003920:Diabetes Mellitus; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control*; D003933:Diagnosis; D004467:Economics; D005190:Family; D030342:Genetic Diseases, Inborn; D005820:Genetic Testing; D015803:HLA-DR3 Antigen / Q000032:analysis*; D015804:HLA-DR4 Antigen / Q000032:analysis*; D006650:Histocompatibility Testing; D006805:Human Experimentation; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000517:prevention & control; D008403:Mass Screening; D005791:Patient Care; D011236:Prediabetic State / Q000175:diagnosis*; D015995:Prevalence; D011315:Preventive Medicine; D012107:Research Design; D012306:Risk; D018570:Risk Assessment; D012307:Risk Factors
Biomedical and Behavioral Research; Genetics and Reproduction; Health Care and Public Health